US dialysis market

Vifor Pharma and Cara Therapeutics sign US license agreement for i.v. Korsuva™* to treat dialysis patients with pruritus

St. Gallen, Switzerland & Stamford, Conn., United States:  Vifor Pharma secures US commercial rights for i.v. Korsuva in non-Fresenius Medical…

Read More »